Genetic variation of the apo AI-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis

Journal of Korean Medical Science

Volumn 15, Issue 3, 2000, Pages 289-294

  Choi, Gyeong Ran ^a   Suh, Soon Pal ^b   Song, Jeong Won ^b   Kee, Seung Jung ^b   Shin, Jong Hee ^b   Ryang, Dong Wook ^b  

^a Honam Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Hypertriglyceridemia; Kidney Failure, Chronic; MspI; Polymorphism, Restriction Fragment Length; SstI

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MULTIGENE FAMILY; RENAL REPLACEMENT THERAPY;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; APOLIPOPROTEINS C; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIGENE FAMILY; RENAL DIALYSIS; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 0034200665     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2000.15.3.289     Document Type: Article

References (29)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701.
2. Merrill JP. Cardiovascular problems in patients on long-term hemodialysis [editorial]. JAMA 1974; 228: 1149.
3. Suki WN, Eknoyan G. Pathophysiology and manifestations of chronic renal failure and the uremic syndrome. In: Jacobson HR, Striker GE, Klahr S, eds. The principles and practice of nephrology. 2nd ed. St. Louis: Mosby, 1995; 605-7.
4. David GW. Chronic renal failure. In: Bennett JC, Plum F, eds. Cecil textbook of medicine. 20th ed. Philadelphia: Saunders, 1996; 556-63.
5. Walli AK, Grone E, Miller B, Grone H-J, Thiery J, Seidel D. Role of lipoproteins in progressive renal disease. Am J Hypertens 1993; 6: 358S-66S.
6. Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadoa L, Sherrard DJ. Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 1977; 26: 903-10.
7. Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21: 573-92.
8. Stein EA, Myers GL. Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia: Saunders, 1994; 1002-94.
9. Wakabayashi Y, Okubo M, Shimada H, Sato N, Koide A, Marumo F, Nakamura H. Decreased VLDL apolipoprotein CII/apolipoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment. Metabolism 1987; 36: 815-20.
10. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR. High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 1988; 60: 397-403.
11. Ferns GA, Galton DJ. Haplotypes of the human apolipoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis. Hum Genet 1986; 73: 245-9.
12. De-Lorenzo F, Monticelli A, Cocozza S, De-Simone B, Rubba P. Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy. Clin Invest 1994; 72: 435-41.
13. Ferns GA, Stocks J, Ritchie C, Galton DJ. Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet 1985; 8450: 300-3.
14. Cooper DN, Clayton JF. DNA polymorphism and the study of disease association. Hum Genet 1988; 78: 299-312.
15. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowelt NI, Baralle FE, Galton DJ. Deoxyribonucleic acid polymorphism in the apolipoprotein AI-CIII gene cluster: association with hypertriglyceridemia. J Clin Invest 1985; 76: 1090-5.
16. Ahn YI, Valdez R, Reddy AP, Cole SA, Weiss KM, Ferrell RE. DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influence plasma cholesterol and triglyceride levels in the Mayans of the Yucatan Peninsula, Mexico. Hum Hered 1991; 41: 281-9.
17. Aalto-Setala K, Kontula K, Sane T, Nieminen M, Nikkila E. DNA polymorphisms of apolipoprotein AI/CIII and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis 1987; 66: 145-52.
18. Hong SH, Park WH, Lee CC, Song JH, Kim JQ. Association between genetic variation of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 1997; 43: 13-7.
19. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 1995; 95: 371-5.
20. Paul M, Galton D, Stocks J. DNA polymorphic patterns and haplotype arrangements of the apo A-I, apo C-III, apo A-IV gene clusters in different ethnic groups. Hum Genet 1987; 75: 264-8.
21. Stocks J, Paul M, Galton G. Haplotypes identified by DNA restriction fragment length polymorphisms in the AI-CIII-AIV gene region and hypertriglyceridemia. Am J Hum Genet 1987; 41: 106-18.
22. Xu CF, Talmud P, Schuster H, Houston R, Miller G, Humphries S. Association between genetic variation at the apo AI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin Genet 1994; 46: 385-97.
23. Castelli WP. The triglyceride issue; a view from Framingham. Am Heart J 1986; 112: 432-7.
24. Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P. Lipoprotein abnormalities without hyperlipidemia in moderate renal insufficiency. Nephrol Dial Transplant 1994; 9: 1580-5.
25. Attman PO, Alaupovic P, Tavella M, Knight-Gibson C. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol Dial Transplant 1996; 11: 63-9.
26. Goldberg A, Sherrard DJ, Brunzell JD. Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism. J Clin Endocrinol Metab 1978; 47: 1173-82.
27. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 1985; 75: 384-90.
28. Holdsworth G, Stocks J, Dodson P, Galton DJ. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. J Clin Invest 1982; 69: 932-9.
29. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 1992; 90: 1889-900.